GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Total Debt per Share

Endo (NDOI) Total Debt per Share : $32.50 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Endo Total Debt per Share?

$32.50 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Endo's Total Debt Per Share for the quarter that ended in Dec. 2024 was $32.50.


Endo Total Debt per Share Historical Data

The historical data trend for Endo's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Total Debt per Share Chart

Endo Annual Data
Trend Dec22 Dec23 Dec24
Total Debt per Share
- 0.08 32.50

Endo Quarterly Data
Jun23 Sep23 Dec23 Apr24 Sep24 Dec24
Total Debt per Share Get a 7-Day Free Trial - 0.08 - 32.39 32.50

Endo Total Debt per Share Calculation

Endo's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Endo's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Endo Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Endo's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo Business Description

Traded in Other Exchanges
N/A
Address
9 Great Valley Parkway, Malvern, PA, USA, 19355
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.